Vasar V - Search Results

1

Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J. Shlik J, et al. Among authors: vasar v, vasar e. J Psychiatry Neurosci. 1997 Nov;22(5):332-40. J Psychiatry Neurosci. 1997. PMID: 9401314 Free PMC article. Clinical Trial.

2

Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.

Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J. Tõru I, et al. Among authors: vasar v. Psychiatry Res. 2010 Jul 30;178(2):342-7. doi: 10.1016/j.psychres.2010.04.003. Epub 2010 May 14. Psychiatry Res. 2010. PMID: 20471107

3

Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ. Tõru I, et al. Among authors: vasar v. Psychopharmacology (Berl). 2006 May;186(1):107-12. doi: 10.1007/s00213-006-0351-1. Epub 2006 Mar 16. Psychopharmacology (Berl). 2006. PMID: 16541242 Clinical Trial.

4

Citalopram challenge in social anxiety disorder.

Shlik J, Maron E, Tru I, Aluoja A, Vasar V. Shlik J, et al. Among authors: vasar v. Int J Neuropsychopharmacol. 2004 Jun;7(2):177-82. doi: 10.1017/S146114570300405X. Epub 2004 Jan 23. Int J Neuropsychopharmacol. 2004. PMID: 14741063 Free article. Clinical Trial.

5

Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.

Aluoja A, Shlik J, Vasar V, Kingisepp PH, Jagomägi K, Vasar E, Bradwejn J. Aluoja A, et al. Among authors: vasar v, vasar e. Psychiatry Res. 1997 Jan 15;66(1):59-67. doi: 10.1016/s0165-1781(96)02948-4. Psychiatry Res. 1997. PMID: 9061804 Clinical Trial.

6

The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers.

Shlik J, Vasar V, Aluoja A, Kingisepp PH, Jagomägi K, Vasar E, Rägo L, Bradwejn J. Shlik J, et al. Among authors: vasar v, vasar e. Biol Psychiatry. 1997 Aug 1;42(3):206-12. doi: 10.1016/s0006-3223(96)00334-4. Biol Psychiatry. 1997. PMID: 9232213 Clinical Trial.

7

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

Kõks S, Männistö PT, Bourin M, Shlik J, Vasar V, Vasar E. Kõks S, et al. Among authors: vasar v, vasar e. J Psychiatry Neurosci. 2000 Jan;25(1):33-42. J Psychiatry Neurosci. 2000. PMID: 10721682 Free PMC article.

8

The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.

Maron E, Tõru I, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. J Psychopharmacol. 2004 Jun;18(2):194-9. doi: 10.1177/0269881104042619. J Psychopharmacol. 2004. PMID: 15260907 Clinical Trial.

9

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E. Eller T, et al. Among authors: vasar v. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):445-50. doi: 10.1016/j.pnpbp.2007.09.015. Epub 2007 Sep 26. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17976882 Clinical Trial.

10

Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.

Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. Neurosci Lett. 2008 Dec 3;446(2-3):88-92. doi: 10.1016/j.neulet.2008.09.052. Neurosci Lett. 2008. PMID: 18832011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters